Extramural Funding Opportunities
The Agency for Healthcare Research and Quality’s (AHRQ) mission is to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. As 1 of 12 agencies within the US Department of Health and Human Services, AHRQ supports research that helps people make more informed decisions and improves the quality of health care services.
AHRQ’s overall focus is:
- Safety and quality: Reduce the risk of harm by promoting delivery of the best possible health care.
- Effectiveness: Improve health care outcomes by encouraging the use of evidence to make informed health care decisions.
- Efficiency: Transform research into practice to facilitate wider access to effective health care services and reduce unnecessary costs.
The Centers for Medicare & Medicaid Services (CMS) provides direction and technical guidance for the administration of the Federal effort to plan, develop, manage and evaluate health care financing programs and policies. The research programs at CMS help develop, test, and implement new health care financing and payment policies. They also evaluate the impact of CMS programs on beneficiaries, providers, States, and other customers and partners. The scope of these activities embraces all areas of health care: costs, access, quality, service delivery models, and financing and payment approaches. Generally, the Agency’s extramural research and demonstration activities, such as evaluations, demonstration implementation, and research studies, are funded through contracts. In addition, CMS periodically issues special-purpose grant announcements inviting applications to participate in specific Medicare and Medicaid demonstration projects.
The mission of the National Center for Advancing Translational Sciences (NCATS) of NIH is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. NCATS supports an array of grant programs and in-kind services designed to support this mission, and develops funding opportunity announcements (FOAs) with an aim to stimulate translational research in areas of greatest need and for identified gaps in diagnostics and therapy development.
Recent FOAs include:
- Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U01)
RFA-TR-13-003 · October 21, 2013
- Centers of Excellence for Big Data Computing in the Biomedical Sciences (U54)
RFA-HG-13-009 · July 22, 2013
The Patient-Centered Outcomes Research Institute (PCORI) was created to fund research that will provide patients and those who care for them with the evidence-based information needed to make better-informed health and healthcare decisions. PCORI supports studies that seek to answer questions important to patients and meaningfully involve patients and others across the healthcare community at all stages of the research process. Funding decisions are driven by PCORI’s National Priorities for Research and Research Agenda. The five priority areas are Assessment of Prevention, Diagnosis, and Treatment Options; Improving Healthcare Systems; Communication and Dissemination; Addressing Disparities; and Accelerating Patient-Centered and Methodological Research.